La bourse est fermée
  • CAC 40

    5 598,18
    +31,39 (+0,56 %)
     
  • Euro Stoxx 50

    3 527,79
    +16,85 (+0,48 %)
     
  • Dow Jones

    29 910,37
    +37,90 (+0,13 %)
     
  • EUR/USD

    1,1970
    +0,0057 (+0,48 %)
     
  • Gold future

    1 788,10
    -23,10 (-1,28 %)
     
  • BTC-EUR

    14 387,62
    +216,29 (+1,53 %)
     
  • CMC Crypto 200

    333,27
    -4,23 (-1,25 %)
     
  • Pétrole WTI

    45,53
    -0,18 (-0,39 %)
     
  • DAX

    13 335,68
    +49,11 (+0,37 %)
     
  • FTSE 100

    6 367,58
    +4,65 (+0,07 %)
     
  • Nasdaq

    12 205,85
    +111,44 (+0,92 %)
     
  • S&P 500

    3 638,35
    +8,70 (+0,24 %)
     
  • Nikkei 225

    26 644,71
    +107,40 (+0,40 %)
     
  • HANG SENG

    26 894,68
    +75,23 (+0,28 %)
     
  • GBP/USD

    1,3314
    -0,0042 (-0,32 %)
     

Global Monocyte Activation Tests Industry

ReportLinker
·19 min de lecture

Global Monocyte Activation Tests Market to Reach $19. 9 Million by 2027. Amid the COVID-19 crisis, the global market for Monocyte Activation Tests estimated at US$8. 2 Million in the year 2020, is projected to reach a revised size of US$19.

New York, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Monocyte Activation Tests Industry" - https://www.reportlinker.com/p05961049/?utm_source=GNW
9 Million by 2027, growing at aCAGR of 13.4% over the period 2020-2027. Monocyte Activation Test Kits, one of the segments analyzed in the report, is projected to record 14.7% CAGR and reach US$10.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 12.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.4 Million, While China is Forecast to Grow at 12.9% CAGR

The Monocyte Activation Tests market in the U.S. is estimated at US$2.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.5 Million by the year 2027 trailing a CAGR of 12.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12% and 11.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.We bring years of research experience to this 6th edition of our report. The 173-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Becton, Dickinson & Company

  • Charles River Laboratories International, Inc.

  • Lonza Group AG

  • Merck KgaA

  • Microcoat Biotechnologie GmbH

  • Sanquin

  • Solvias AG

  • Thermo Fisher Scientific, Inc.




Read the full report: https://www.reportlinker.com/p05961049/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Monocyte Activation Tests Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Monocyte
Activation Tests by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027

Table 2: World 7-Year Perspective for Monocyte Activation Tests
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Monocyte
Activation Test Kits by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027

Table 4: World 7-Year Perspective for Monocyte Activation Test
Kits by Geographic Region - Percentage Breakdown of Value Sales
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 5: World Current & Future Analysis for Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 6: World 7-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 7: World Current & Future Analysis for Blood Based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 8: World 7-Year Perspective for Blood Based by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 9: World Current & Future Analysis for Peripheral Blood
Mononuclear Cell (PBMC) Based by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ for Years
2020 through 2027

Table 10: World 7-Year Perspective for Peripheral Blood
Mononuclear Cell (PBMC) Based by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027

Table 11: World Current & Future Analysis for Cell Line Based
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 12: World 7-Year Perspective for Cell Line Based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 13: World Current & Future Analysis for Pharmaceuticals
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 14: World 7-Year Perspective for Pharmaceuticals by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 15: World Current & Future Analysis for Biotechnology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 16: World 7-Year Perspective for Biotechnology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 17: World Current & Future Analysis for Medical Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027

Table 18: World 7-Year Perspective for Medical Devices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 19: World Current & Future Analysis for Other End-Use
Industries by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027

Table 20: World 7-Year Perspective for Other End-Use Industries
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Monocyte Activation Tests Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 21: USA Current & Future Analysis for Monocyte Activation
Tests by Product - Monocyte Activation Test Kits and Reagents -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 22: USA 7-Year Perspective for Monocyte Activation Tests
by Product - Percentage Breakdown of Value Sales for Monocyte
Activation Test Kits and Reagents for the Years 2020 & 2027

Table 23: USA Current & Future Analysis for Monocyte Activation
Tests by Source - Blood Based, Peripheral Blood Mononuclear
Cell (PBMC) Based and Cell Line Based - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027

Table 24: USA 7-Year Perspective for Monocyte Activation Tests
by Source - Percentage Breakdown of Value Sales for Blood
Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell
Line Based for the Years 2020 & 2027

Table 25: USA Current & Future Analysis for Monocyte Activation
Tests by End-Use Industry - Pharmaceuticals, Biotechnology,
Medical Devices and Other End-Use Industries - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 26: USA 7-Year Perspective for Monocyte Activation Tests
by End-Use Industry - Percentage Breakdown of Value Sales for
Pharmaceuticals, Biotechnology, Medical Devices and Other
End-Use Industries for the Years 2020 & 2027

CANADA
Table 27: Canada Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 28: Canada 7-Year Perspective for Monocyte Activation
Tests by Product - Percentage Breakdown of Value Sales for
Monocyte Activation Test Kits and Reagents for the Years 2020 &
2027

Table 29: Canada Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 30: Canada 7-Year Perspective for Monocyte Activation
Tests by Source - Percentage Breakdown of Value Sales for Blood
Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell
Line Based for the Years 2020 & 2027

Table 31: Canada Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 32: Canada 7-Year Perspective for Monocyte Activation
Tests by End-Use Industry - Percentage Breakdown of Value Sales
for Pharmaceuticals, Biotechnology, Medical Devices and Other
End-Use Industries for the Years 2020 & 2027

JAPAN
Table 33: Japan Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 34: Japan 7-Year Perspective for Monocyte Activation
Tests by Product - Percentage Breakdown of Value Sales for
Monocyte Activation Test Kits and Reagents for the Years 2020 &
2027

Table 35: Japan Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 36: Japan 7-Year Perspective for Monocyte Activation
Tests by Source - Percentage Breakdown of Value Sales for Blood
Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell
Line Based for the Years 2020 & 2027

Table 37: Japan Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 38: Japan 7-Year Perspective for Monocyte Activation
Tests by End-Use Industry - Percentage Breakdown of Value Sales
for Pharmaceuticals, Biotechnology, Medical Devices and Other
End-Use Industries for the Years 2020 & 2027

CHINA
Table 39: China Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 40: China 7-Year Perspective for Monocyte Activation
Tests by Product - Percentage Breakdown of Value Sales for
Monocyte Activation Test Kits and Reagents for the Years 2020 &
2027

Table 41: China Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 42: China 7-Year Perspective for Monocyte Activation
Tests by Source - Percentage Breakdown of Value Sales for Blood
Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell
Line Based for the Years 2020 & 2027

Table 43: China Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 44: China 7-Year Perspective for Monocyte Activation
Tests by End-Use Industry - Percentage Breakdown of Value Sales
for Pharmaceuticals, Biotechnology, Medical Devices and Other
End-Use Industries for the Years 2020 & 2027

EUROPE
Market Facts & Figures
European Monocyte Activation Tests Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 45: Europe Current & Future Analysis for Monocyte
Activation Tests by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ for Years 2020 through 2027

Table 46: Europe 7-Year Perspective for Monocyte Activation
Tests by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2020 & 2027

Table 47: Europe Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 48: Europe 7-Year Perspective for Monocyte Activation
Tests by Product - Percentage Breakdown of Value Sales for
Monocyte Activation Test Kits and Reagents for the Years 2020 &
2027

Table 49: Europe Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 50: Europe 7-Year Perspective for Monocyte Activation
Tests by Source - Percentage Breakdown of Value Sales for Blood
Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell
Line Based for the Years 2020 & 2027

Table 51: Europe Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 52: Europe 7-Year Perspective for Monocyte Activation
Tests by End-Use Industry - Percentage Breakdown of Value Sales
for Pharmaceuticals, Biotechnology, Medical Devices and Other
End-Use Industries for the Years 2020 & 2027

FRANCE
Table 53: France Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 54: France 7-Year Perspective for Monocyte Activation
Tests by Product - Percentage Breakdown of Value Sales for
Monocyte Activation Test Kits and Reagents for the Years 2020 &
2027

Table 55: France Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 56: France 7-Year Perspective for Monocyte Activation
Tests by Source - Percentage Breakdown of Value Sales for Blood
Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell
Line Based for the Years 2020 & 2027

Table 57: France Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 58: France 7-Year Perspective for Monocyte Activation
Tests by End-Use Industry - Percentage Breakdown of Value Sales
for Pharmaceuticals, Biotechnology, Medical Devices and Other
End-Use Industries for the Years 2020 & 2027

GERMANY
Table 59: Germany Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 60: Germany 7-Year Perspective for Monocyte Activation
Tests by Product - Percentage Breakdown of Value Sales for
Monocyte Activation Test Kits and Reagents for the Years 2020 &
2027

Table 61: Germany Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 62: Germany 7-Year Perspective for Monocyte Activation
Tests by Source - Percentage Breakdown of Value Sales for Blood
Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell
Line Based for the Years 2020 & 2027

Table 63: Germany Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 64: Germany 7-Year Perspective for Monocyte Activation
Tests by End-Use Industry - Percentage Breakdown of Value Sales
for Pharmaceuticals, Biotechnology, Medical Devices and Other
End-Use Industries for the Years 2020 & 2027

ITALY
Table 65: Italy Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 66: Italy 7-Year Perspective for Monocyte Activation
Tests by Product - Percentage Breakdown of Value Sales for
Monocyte Activation Test Kits and Reagents for the Years 2020 &
2027

Table 67: Italy Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 68: Italy 7-Year Perspective for Monocyte Activation
Tests by Source - Percentage Breakdown of Value Sales for Blood
Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell
Line Based for the Years 2020 & 2027

Table 69: Italy Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 70: Italy 7-Year Perspective for Monocyte Activation
Tests by End-Use Industry - Percentage Breakdown of Value Sales
for Pharmaceuticals, Biotechnology, Medical Devices and Other
End-Use Industries for the Years 2020 & 2027

UNITED KINGDOM
Table 71: UK Current & Future Analysis for Monocyte Activation
Tests by Product - Monocyte Activation Test Kits and Reagents -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 72: UK 7-Year Perspective for Monocyte Activation Tests
by Product - Percentage Breakdown of Value Sales for Monocyte
Activation Test Kits and Reagents for the Years 2020 & 2027

Table 73: UK Current & Future Analysis for Monocyte Activation
Tests by Source - Blood Based, Peripheral Blood Mononuclear
Cell (PBMC) Based and Cell Line Based - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027

Table 74: UK 7-Year Perspective for Monocyte Activation Tests
by Source - Percentage Breakdown of Value Sales for Blood
Based, Peripheral Blood Mononuclear Cell (PBMC) Based and Cell
Line Based for the Years 2020 & 2027

Table 75: UK Current & Future Analysis for Monocyte Activation
Tests by End-Use Industry - Pharmaceuticals, Biotechnology,
Medical Devices and Other End-Use Industries - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 76: UK 7-Year Perspective for Monocyte Activation Tests
by End-Use Industry - Percentage Breakdown of Value Sales for
Pharmaceuticals, Biotechnology, Medical Devices and Other
End-Use Industries for the Years 2020 & 2027

REST OF EUROPE
Table 77: Rest of Europe Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 78: Rest of Europe 7-Year Perspective for Monocyte
Activation Tests by Product - Percentage Breakdown of Value
Sales for Monocyte Activation Test Kits and Reagents for the
Years 2020 & 2027

Table 79: Rest of Europe Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 80: Rest of Europe 7-Year Perspective for Monocyte
Activation Tests by Source - Percentage Breakdown of Value
Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC)
Based and Cell Line Based for the Years 2020 & 2027

Table 81: Rest of Europe Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 82: Rest of Europe 7-Year Perspective for Monocyte
Activation Tests by End-Use Industry - Percentage Breakdown of
Value Sales for Pharmaceuticals, Biotechnology, Medical Devices
and Other End-Use Industries for the Years 2020 & 2027

ASIA-PACIFIC
Table 83: Asia-Pacific Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 84: Asia-Pacific 7-Year Perspective for Monocyte
Activation Tests by Product - Percentage Breakdown of Value
Sales for Monocyte Activation Test Kits and Reagents for the
Years 2020 & 2027

Table 85: Asia-Pacific Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 86: Asia-Pacific 7-Year Perspective for Monocyte
Activation Tests by Source - Percentage Breakdown of Value
Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC)
Based and Cell Line Based for the Years 2020 & 2027

Table 87: Asia-Pacific Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 88: Asia-Pacific 7-Year Perspective for Monocyte
Activation Tests by End-Use Industry - Percentage Breakdown of
Value Sales for Pharmaceuticals, Biotechnology, Medical Devices
and Other End-Use Industries for the Years 2020 & 2027

REST OF WORLD
Table 89: Rest of World Current & Future Analysis for Monocyte
Activation Tests by Product - Monocyte Activation Test Kits and
Reagents - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027

Table 90: Rest of World 7-Year Perspective for Monocyte
Activation Tests by Product - Percentage Breakdown of Value
Sales for Monocyte Activation Test Kits and Reagents for the
Years 2020 & 2027

Table 91: Rest of World Current & Future Analysis for Monocyte
Activation Tests by Source - Blood Based, Peripheral Blood
Mononuclear Cell (PBMC) Based and Cell Line Based - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027

Table 92: Rest of World 7-Year Perspective for Monocyte
Activation Tests by Source - Percentage Breakdown of Value
Sales for Blood Based, Peripheral Blood Mononuclear Cell (PBMC)
Based and Cell Line Based for the Years 2020 & 2027

Table 93: Rest of World Current & Future Analysis for Monocyte
Activation Tests by End-Use Industry - Pharmaceuticals,
Biotechnology, Medical Devices and Other End-Use Industries -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027

Table 94: Rest of World 7-Year Perspective for Monocyte
Activation Tests by End-Use Industry - Percentage Breakdown of
Value Sales for Pharmaceuticals, Biotechnology, Medical Devices
and Other End-Use Industries for the Years 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 41
Read the full report: https://www.reportlinker.com/p05961049/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001